QNT Stock: Will Oracle Partnership Help Quantinuum Turn Hype into Growth?

Quantum computing has an extraordinary capacity to induce excitement among investors, despite repeated warnings from analysts that the sector is years away from making decent money. 

While major tech firms and specialised hardware makers project widespread commercial utility and fault-tolerant scaling between 2029 and 2035, timelines depend heavily on overcoming major error-correction and hardware hurdles.

Notwithstanding this, the hype continues to mount. Thus, even if leading pure-play firms themselves are not turning a profit, their share prices have logged impressive growth over the last year or so. 

The latest quantum stock to join the fray is Quantinuum [QNT], which went public at the start of June.

The company sold 28m shares at $60 each to raise roughly $1.68bn, securing an initial market valuation above $15bn.

Founded in 2021 through the merger of Honeywell’s [HON] quantum computing division and UK-based Cambridge Quantum, Quantinuum describes itself as a “full-stack quantum computing platform”, developing both the underlying hardware and the software that runs on it.

In its S-1 filing, the firm said its customer base spans pharmaceuticals, materials science, finance, government and industry, and includes such names as JPMorgan Chase [JPM] and Amgen [AMGN].

In an interview with CNBC to mark the IPO, CEO Rajeeb Hazra conceded that quantum adoption is still at an early stage, but the “need for these kinds of computing resources is absolutely a given.”

QNT stock trended downwards following its IPO. It saw a spike after its first earnings call on 10 August, only to drop again below its IPO price of $68 per share.

This stock analysis will unpack the implications of Quantinuum’s partnership with Oracle [ORCL], dive into its Q2 numbers and then sketch the medium-term prognosis for the stock.

Quantinuum brings Helios to Oracle Cloud

Earlier in August, Quantinuum announced a multi-year partnership with Oracle to bring its Helios quantum computer to Oracle Cloud Infrastructure (OCI). The deal will give OCI customers managed access to Helios alongside Oracle’s high-performance computing (HPC) and GPU infrastructure, removing the need to buy or operate specialised quantum hardware.

The partnership is significant because it positions quantum computing as a complement to, rather than a replacement for, conventional computing and artificial intelligence (AI). Quantinuum and Oracle plan to develop hybrid workloads combining quantum processors, GPUs and classical supercomputers for computationally intensive applications including drug discovery, materials science, logistics, energy and financial modelling.

Helios is a 98-physical-qubit trapped-ion system, launched commercially in November 2025. Quantinuum says it has demonstrated 48 logical qubits and average two-qubit gate fidelity of 99.921%, highlighting the system’s focus on accuracy as well as scale. The company also claims Helios consumes less than 1% of the power of leading supercomputers, potentially giving quantum systems an efficiency advantage for suitable workloads.

For investors, the immediate revenue impact is likely to be limited, but the deal could be strategically important. Integrating Helios into OCI gives Quantinuum access to Oracle’s large enterprise customer base and lowers the barrier to experimenting with quantum computing, potentially accelerating commercial adoption as the technology matures.

Revenue growth comes with hefty losses

Quantinuum’s first quarterly results as a public company highlight both the rapid growth of its commercial business and the substantial costs of developing quantum computing technology. Q2 revenue jumped 279% year-on-year to $8m, up from $2m a year earlier. While the percentage growth is striking, it comes from a small base, meaning the company remains at an early stage of commercialisation.

Quantinuum expects full-year 2026 revenue of $28m-32m.

The company’s losses, however, remain substantial. GAAP net loss widened to $597m from $57m a year earlier, while adjusted EBITDA loss increased to $68m from $43m. GAAP loss attributable to Class A common shareholders was $1.93 a share, compared with an adjusted net loss of $0.28 a share.

Gross margins provide a more encouraging signal. GAAP gross margin was negative 64.4%, although this represented a 27-percentage-point improvement y/y. Adjusted gross margin stood at 62%, slightly below 62.6% a year earlier. The disparity reflects the heavy investment required to develop quantum hardware and infrastructure.

Quantinuum’s balance sheet nevertheless gives it considerable room to invest. Following its IPO, the company ended June with $2.1bn in cash, cash equivalents and short-term investments. That capital should help fund its technology roadmap without the immediate need for another major capital raise.

Hardware roadmap and commercial partnerships

Quantinuum is using its post-IPO capital to advance a demanding hardware roadmap, with its Helios system now commercially available and Sol targeted for 2027. Its Nexus cloud platform is already being used by 180 organisations, providing a route for customers to access its quantum capabilities without owning the underlying hardware.

Alongside the Oracle partnership, a collaboration with Hewlett Packard Enterprise [HPE] is focused on integrating quantum computing with HPC and AI environments. The strategy reflects the likely role of quantum processors as specialised accelerators working alongside CPUs, GPUs and other conventional systems rather than replacing them.

For Quantinuum, these partnerships could ultimately prove important beyond their near-term revenue contribution, giving the company access to established enterprise ecosystems as it works to turn its technical advances into a much larger commercial market. 

Quantinuum is also seeking to translate advances in quantum performance into practical applications. It developed a quantum phase-estimation algorithm for molecular modelling and worked with Nvidia [NVDA] and a Fortune 100 pharmaceutical company on AI-driven quantum simulation. The company also reported simulations of complex magnetic materials beyond the practical capabilities of classical computers. 

Conclusion: The investment case for QNT stock

Quantinuum offers investors exposure to one of the most promising, but speculative, areas of next-generation computing. Its 279% revenue growth, $2.1bn cash pile and partnerships with Oracle and HPE provide evidence that the company is making progress towards commercialisation. Its trapped-ion technology and full-stack approach could also give it an advantage if quantum computing begins to achieve meaningful commercial scale.

However, the investment case remains highly dependent on what happens several years from now. Revenue of just $28m-32m expected for 2026 looks small against a post-IPO valuation above $15bn, while the $597m GAAP loss underlines the cost of developing the technology. The Oracle deal is strategically encouraging, but it is not yet evidence of substantial near-term revenue.

For investors, therefore, QNT stock looks less like a conventional growth investment and more like a high-risk bet on quantum computing becoming commercially viable. Its substantial cash reserves provide a useful buffer, but the valuation leaves little room for delays or technological setbacks.

CMC Aureon’s proprietary theme relevance system maps the world’s biggest investing megatrends. For in-depth analyses of stocks with high growth potential, subscribe to CMC Aureon Foresight.